These findings demonstrate that DHRS4-AS1/miR-224-3p signaling and downstream genes, TP53 and TET1 play important roles in the cancer cell stemness of NSCLC in vitro and in vivo. The gene discussed is TP53; the disease is non-small cell lung carcinoma.